Ajouté récemment

Representation of Women Among Individuals With Mild Variants in ABCA4-Associated Retinopathy: A Meta-Analysis

Cornelis, Stéphanie S.; Inthout, Joanna; Runhart, Esmee H.; et al.

JAMA Ophthalmology, American Medical Association, 11-04-2024, 142 (5), 463-471

Article dans une revue scientifique

Early automated classification of neonatal hypoxic-ischemic encephalopathy - An aid to the decision to use therapeutic hypothermia.

Lacan, Laure; Betrouni, Nacim; Chaton, Laurence; et al.

Clinical Neurophysiology, 10-2024, 166, 108-116

Article dans une revue scientifique

Neural correlates of distress and comfort in individuals with avoidant, anxious and secure attachment style: an fMRI study.

Comte, Alexandre; Szymanska, Monika; Monnin, Julie; et al.

Attachment and Human Development, 02-08-2024, 26, 423-445

Article dans une revue scientifique

Real-Time Symptom Capture of Hallucinations in Schizophrenia with fMRI: Absence of Duration-Dependent Activity.

Gill, Karanvir; Percival, Chantal; Roes, Meighen; et al.

Schizophrenia Bulletin Open, 01-2022, 3

Article dans une revue scientifiquetexte intégral

Bulbar muscle impairment in patients with late onset Pompe disease: Insight from the French Pompe registry.

Retailleau, Emilie; Lefeuvre, Claire; De Antonio, Marie; et al.

European Journal of Neurology, 10-2024, 31

Article dans une revue scientifiquetexte intégral

Idiopathic normal-pressure hydrocephalus: diagnostic accuracy of automated sulcal morphometry in patients with ventriculomegaly

Kuchcinski, Gregory; Jacquiez, Caroline; Baroncini, Marc; et al.

Neurosurgery, 22-05-2019

Article dans une revue scientifique

Identifying Gaps and Barriers in Alzheimer's Disease and Related Dementia Research and Management in Low- and Middle-Income Countries: A Survey of Health Professionals and Researchers.

Babulal, Ganesh M.; Zha, Wenqing; Trani, Jean-François; et al.

Journal of Alzheimer's Disease, 08-10-2024, 101, 1307-1320

Article dans une revue scientifique

Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.

Montalban, Xavier; Vermersch, Patrick; Arnold, Douglas L.; et al.

The Lancet Neurology, 11-2024, 23, 1119-1132

Article dans une revue scientifique

Lille Neurosciences & Cognition (LilNCog) - U 1172: dépôt récent

Recent advances, challenges and perspectives in cerebrovascular disease.

Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review

Representation of Women Among Individuals With Mild Variants in ABCA4-Associated Retinopathy: A Meta-Analysis

Early automated classification of neonatal hypoxic-ischemic encephalopathy - An aid to the decision to use therapeutic hypothermia.

Neural correlates of distress and comfort in individuals with avoidant, anxious and secure attachment style: an fMRI study.

Real-Time Symptom Capture of Hallucinations in Schizophrenia with fMRI: Absence of Duration-Dependent Activity.

Bulbar muscle impairment in patients with late onset Pompe disease: Insight from the French Pompe registry.

Idiopathic normal-pressure hydrocephalus: diagnostic accuracy of automated sulcal morphometry in patients with ventriculomegaly

Identifying Gaps and Barriers in Alzheimer's Disease and Related Dementia Research and Management in Low- and Middle-Income Countries: A Survey of Health Professionals and Researchers.

Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.

Lille Neurosciences & Cognition (LilNCog) - U 1172: dépôt récent

Recent advances, challenges and perspectives in cerebrovascular disease. ﻿

Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review ﻿

Representation of Women Among Individuals With Mild Variants in ABCA4-Associated Retinopathy: A Meta-Analysis ﻿

Early automated classification of neonatal hypoxic-ischemic encephalopathy - An aid to the decision to use therapeutic hypothermia. ﻿

Neural correlates of distress and comfort in individuals with avoidant, anxious and secure attachment style: an fMRI study. ﻿

Real-Time Symptom Capture of Hallucinations in Schizophrenia with fMRI: Absence of Duration-Dependent Activity. ﻿

Bulbar muscle impairment in patients with late onset Pompe disease: Insight from the French Pompe registry. ﻿

Idiopathic normal-pressure hydrocephalus: diagnostic accuracy of automated sulcal morphometry in patients with ventriculomegaly ﻿

Identifying Gaps and Barriers in Alzheimer's Disease and Related Dementia Research and Management in Low- and Middle-Income Countries: A Survey of Health Professionals and Researchers. ﻿

Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials. ﻿

Recent advances, challenges and perspectives in cerebrovascular disease.

Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review

Representation of Women Among Individuals With Mild Variants in ABCA4-Associated Retinopathy: A Meta-Analysis

Early automated classification of neonatal hypoxic-ischemic encephalopathy - An aid to the decision to use therapeutic hypothermia.

Neural correlates of distress and comfort in individuals with avoidant, anxious and secure attachment style: an fMRI study.

Real-Time Symptom Capture of Hallucinations in Schizophrenia with fMRI: Absence of Duration-Dependent Activity.

Bulbar muscle impairment in patients with late onset Pompe disease: Insight from the French Pompe registry.

Idiopathic normal-pressure hydrocephalus: diagnostic accuracy of automated sulcal morphometry in patients with ventriculomegaly

Identifying Gaps and Barriers in Alzheimer's Disease and Related Dementia Research and Management in Low- and Middle-Income Countries: A Survey of Health Professionals and Researchers.

Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.